Company Filing History:
Years Active: 2022-2025
Title: Innovations by Nicolas Hebert
Introduction
Nicolas Hebert is a notable inventor based in Ollainville, France. He has made significant contributions to the field of medical technology, particularly in the area of hematology. With a total of 2 patents, his work focuses on methods for analyzing hemoglobin content in erythroid cells.
Latest Patents
Nicolas Hebert's latest patents include two innovative methods that utilize flow cytometry. The first patent is a method for determining the hemoglobin content of an erythroid cell. This invention is particularly useful for assessing the hemoglobin levels in red blood cells, which is crucial for monitoring patients with conditions such as sickle cell disease or β-thalassemia. The second patent involves a method for determining the hemoglobin F (HbF) content of erythroid cells. Similar to the first, this method aids in evaluating the HbF levels in red blood cells and is also applicable in monitoring transfusions and treatment efficacy for patients suffering from specific blood disorders.
Career Highlights
Throughout his career, Nicolas Hebert has worked with esteemed institutions such as Université Paris Est Créteil Val De Marne and the Institut National de la Santé et de la Recherche Médicale. His experience in these organizations has allowed him to develop and refine his innovative methods, contributing to advancements in medical research and patient care.
Collaborations
Nicolas has collaborated with several professionals in his field, including France Noizat Pirenne and Marie Georgine Rakotoson. These collaborations have further enriched his research and development efforts, leading to impactful innovations in hematology.
Conclusion
Nicolas Hebert's contributions to medical technology through his patents demonstrate his commitment to improving patient outcomes in hematological conditions. His innovative methods for analyzing hemoglobin content are vital tools in modern medicine.